Evidence map›Paper›PMID 37139158›Full record

ArticleFrontiers in oncology2023

Trends in cutaneous squamous cell carcinoma on the lip incidence and mortality in the United States, 2000-2019.

Jin Zhang, Quyang Yang, Jinyan Wu, Ruoyue Yuan, Xiansheng Zhao, Yue Li, Xiujun Cheng, Baojin Wu, Ningwen Zhu

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Frontiers in oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Jin ZhangDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Quyang YangDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Jinyan WuDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Ruoyue YuanDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Xiansheng ZhaoDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Yue LiDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Xiujun ChengDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Baojin WuHuashan Hospital, Fudan University, Shanghai, China.
Ningwen ZhuDepartment of Dermatology, Shanghai Institute of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.
Huashan Hospital · CNFudan University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Objective: This study provided a systematic analysis of the trend in incidence and incidence-based mortality for cutaneous squamous cell carcinoma (cSCC) on the lips in the USA using demographic characteristics from the Surveillance, Epidemiology, and End Results (SEER) database. Methods: Patients diagnosed with cSCC on the lips between 2000 and 2019 from the 17 registries of the USA were identified. Incidence and incidence-based mortality rates were analyzed using SEER*Stat 8.4.0.1 software. This paper calculated incidence rates and incidence-based mortality rates by 100,000 person-years for sex, age, race, SEER registries, median household income ($/year), rural-urban distribution, and primary site. The annual percent changes (APC) in incidence and incidence-based mortality rates were then calculated using joinpoint regression software. Results: Among 8,625 patients diagnosed with cSCC on the lips from 2000 to 2019, men (74.67%), white (95.21%), and 60-79 years old were the most common population, and 3,869 deaths from cSCC on the lips occurred. The overall incidence of cSCC on the lips was 0.516 per 100,000 person-years. cSCC on the lip incidence rates were highest among men, white, and patients aged 60-79 years old. cSCC on the lip incidence rates decreased by 3.210%/year over the study period. The incidence of cSCC on the lips has been decreasing in all sexes, ages, high- or low-income households, and urban or rural patients. The overall incidence-based mortality rate of cSCC on the lips during 2000-2019 was 0.235 per 100,000 person-years. cSCC on the lip incidence-based mortality rates were highest among men, whites, and people older than 80 years old. cSCC on the lip incidence-based mortality increased by 4.975%/year over the study period. cSCC on the lip incidence-based mortality rates increased for all sexes, races, ages, primary sites, high- or low-income households, and urban or rural patients during the study period. Conclusion: Among patients in the USA diagnosed with cSCC on the lips from 2000 to 2019, the overall incidence decreased by 3.210% annually, and incidence-based mortality increased by 4.975%/year. These findings update and supplement the epidemiological information of cSCC on the lips in the USA.

Indexed as

annual percent changes (APC)cSCC on the lipscutaneous squamous cell carcinoma (cSCC)incidenceincidence-based mortality

Identifiers

PMID37139158
PMCPMC10149798
OpenAlexW4366207694

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.